Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × DLL3 protein, human × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Neuroendocrine 1

Interventions

Specimen Handling 427 pembrolizumab 420 Magnetic Resonance Spectroscopy 369 Carboplatin 300 Cyclophosphamide 270 Cisplatin 254 Biopsy 237 Radiotherapy 213 Gemcitabine 198 Paclitaxel 197 Bevacizumab 185 Nivolumab 170 venetoclax 166 fludarabine 156 Drug Therapy 145 Blood Specimen Collection 144 Dexamethasone 139 Docetaxel 135 Oxaliplatin 133 Injections 133 Fluorouracil 131 Capecitabine 131 Radiosurgery 122 Rituximab 121 Standard of Care 118 Pemetrexed 114 atezolizumab 104 durvalumab 100 Radiation 100 Doxorubicin 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06893783 2025-09-08

DeLLight

Asan Medical Center

Phase 2 Recruiting

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡